Roger Strode Featured in Q&A on the Rise of Private Equity Investments in Cardiology
February 15, 2023
Cardiovascular Business
Foley & Lardner LLP Partner Roger Strode is featured in the Cardiovascular Business Q&A “What the rise of private equity investments in cardiology means for cardiologists and their patients.”
Strode explains the trend of recapitalization transactions in the health care space, what makes cardiology so appealing to investors right now, and the long-term strategy of and perspectives on these investments.
People
Related News
July 18, 2025
In the News
Matt Caplan Featured for Arrival to Foley – 'It's an exciting time'
Foley & Lardner LLP partner Matt Caplan is highlighted across press for his recent arrival to the firm's San Francisco office.
July 18, 2025
In the News
David Rosen on FDA's CRL Release – 'It hasn't happened in the past'
Foley & Lardner LLP partner David Rosen commented on the U.S. Food and Drug Administration's decision to publish a package of complete response letters to pharmaceutical companies in the PharmaVoice article, "Why FDA’s CRL release could open the door to lawsuits against pharma."
July 18, 2025
In the News
Aaron Maguregui Highlights Potential Compliance Concerns in Pre-Tax Wellness Claims
Foley & Lardner LLP partner Aaron Maguregui commented in The New York Times article, "Hot Dogs for Insomnia? A Kennedy Aide's Start-Up Can Get You a Tax Break," sharing insight on the growing use of medical necessity letters to support tax-advantaged purchases of wellness products.